NEU 2.38% $12.70 neuren pharmaceuticals limited

$4.17-$6.31 Val, page-58

  1. 1,588 Posts.
    lightbulb Created with Sketch. 330
    The Lanstead funding pause, at this stage, hasn't made a material difference to the payment receipts we would have made and are now making. Under the original terms the final payment was due in February but this is now pushed to June. I will be glad once that arrangement ends to see if there is any effect on the SP. RT stated in the pausing announcement on August 28 that the reasoning for the pause was that cash wasn't required and the SP wasn't fully reflective of the underlying business. Obviously, they expected some sort of catalyst to move the SP to an appropriate level during the 4 month pause which hasn't eventuated. I can only see this as possibly being the ROW deal.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.